ARTICLE | Distillery Therapeutics
Cancer
December 13, 2016 8:01 PM UTC
Mouse studies suggest CD19-targeting chimeric antigen receptor (CAR) T cells expressing an IL-15/IL-15RA fusion protein could help treat B cell precursor leukemia. In a xenograft mouse model of the di...